X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (966) 966
Publication (119) 119
Book Review (32) 32
Book / eBook (5) 5
Book Chapter (4) 4
Magazine Article (4) 4
Conference Proceeding (3) 3
Newsletter (3) 3
Reference (3) 3
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (882) 882
meningococcal vaccines - adverse effects (443) 443
index medicus (437) 437
female (414) 414
male (407) 407
meningococcal vaccines - immunology (382) 382
immunology (365) 365
vaccines (355) 355
infant (353) 353
meningococcal vaccines - administration & dosage (333) 333
adolescent (321) 321
child (313) 313
vaccination (284) 284
adult (282) 282
immunization (275) 275
meningococcal infections - prevention & control (266) 266
child, preschool (258) 258
meningitis (240) 240
immunogenicity (225) 225
infectious diseases (221) 221
disease (212) 212
antibodies, bacterial - blood (200) 200
children (196) 196
safety (182) 182
vaccines, conjugate - immunology (167) 167
pediatrics (165) 165
meningitis, meningococcal - prevention & control (160) 160
vaccines, conjugate - adverse effects (154) 154
neisseria-meningitidis (142) 142
infants (141) 141
neisseria meningitidis - immunology (139) 139
immunization schedule (138) 138
medicine, research & experimental (130) 130
young adult (130) 130
meningococcal disease (124) 124
neisseria meningitidis (124) 124
vaccines, conjugate - administration & dosage (117) 117
meningococcal vaccines (116) 116
epidemiology (115) 115
middle aged (112) 112
neisseria meningitidis, serogroup b - immunology (106) 106
prevention (105) 105
conjugate vaccine (96) 96
united-states (91) 91
meningococcal infections - epidemiology (90) 90
public health (90) 90
allergy and immunology (86) 86
vaccine (86) 86
age (85) 85
research (85) 85
microbiology (83) 83
health aspects (82) 82
bacterial vaccines - adverse effects (79) 79
heptavalent pneumococcal conjugate vaccine (79) 79
medicine, general & internal (78) 78
meningococcal infections - immunology (75) 75
risk factors (75) 75
adolescents (74) 74
meningococcal vaccines - therapeutic use (74) 74
immunization, secondary (70) 70
pneumococcal vaccines - adverse effects (70) 70
proteins (70) 70
treatment outcome (69) 69
vaccination - adverse effects (68) 68
antibodies (66) 66
meningococcal infections (66) 66
pneumococcal vaccines - administration & dosage (66) 66
tetanus (66) 66
clinical trials (64) 64
polysaccharides, bacterial - immunology (64) 64
efficacy (62) 62
infant, newborn (62) 62
meningitis, meningococcal - epidemiology (62) 62
meningitis, meningococcal - immunology (62) 62
mortality (62) 62
biotechnology & applied microbiology (60) 60
immune response (60) 60
teenagers (60) 60
pneumococcal vaccines - immunology (57) 57
blood bactericidal activity (56) 56
meningococcal vaccine (55) 55
animals (54) 54
vaccination - methods (54) 54
polysaccharides (52) 52
adults (51) 51
conjugate vaccines (51) 51
pneumococcal infections - prevention & control (51) 51
united states (51) 51
antigens (50) 50
children & youth (50) 50
meningococcal infections - microbiology (50) 50
diphtheria (49) 49
bacterial outer membrane proteins - immunology (48) 48
incidence (48) 48
medical research (48) 48
protection (48) 48
surveillance (48) 48
time factors (48) 48
research article (47) 47
abridged index medicus (46) 46
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (944) 944
Spanish (10) 10
French (9) 9
Russian (5) 5
Chinese (4) 4
Dutch (4) 4
German (4) 4
Norwegian (4) 4
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 14, pp. 1758 - 1763
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 25, pp. 4264 - 4273
Abstract Tetravalent meningococcal serogroups ACWY conjugate vaccines will provide an advantage to those at most risk of invasive meningococcal disease; namely... 
Allergy and Immunology | Tetravalent meningococcal vaccine | Hexavalent vaccine | Conjugate vaccine | DTaP-HBV-IPV/Hib combination vaccine | Bactericidal activity | MEDICINE, RESEARCH & EXPERIMENTAL | NEISSERIA-MENINGITIDIS | PREVENTION | IMMUNOSORBENT-ASSAY ELISA | SERUM ANTIBODIES | IMMUNOLOGY | PROTECTIVE LEVEL | TODDLERS | CAPSULAR POLYSACCHARIDE | IMPACT | INFLUENZAE TYPE-B | DISEASE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Infant | Male | Haemophilus Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Vaccines, Conjugate - immunology | Female | Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-acellular Pertussis Vaccines - immunology | Tetanus Toxoid - adverse effects | Haemophilus Vaccines - immunology | Tetanus Toxoid - administration & dosage | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Poliovirus Vaccine, Inactivated - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Tetanus Toxoid - immunology
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 3, pp. 452 - 458
Highlights • DTaP-IPV-HB-PRP-T immunogenicity is similar when given concomitantly with a meningococcal C conjugate vaccine or alone. • The safety profile of... 
Allergy and Immunology | Co-administration | Meningococcal C | Safety | Immunogenicity | Vaccination | Hexavalent | MEDICINE, RESEARCH & EXPERIMENTAL | DIFFERENCE | COMBINATION VACCINES | B VACCINE | IMMUNOLOGY | TETANUS TOXOID CONJUGATE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Healthy Volunteers | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Hepatitis B Antibodies - blood | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Immunization Schedule | Antibodies, Bacterial - blood | Rotavirus Vaccines - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Finland | Poliovirus Vaccine, Inactivated - adverse effects | Hepatitis B Vaccines - immunology | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Usage | Infants | Vaccines | Antigens | Hepatitis | Immunization | Pain | Poliomyelitis | Viruses | Tetanus | Diphtheria | Age | Whooping cough
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2010, Volume 51, Issue 10, pp. 1127 - 1137
Background. In the absence of an efficacious broadly protective vaccine, serogroup B Neisseria meningitidis (MenB) is the leading cause of bacterial meningitis... 
Antigens | Immune response | Vaccination | Vaccine components | Antibodies | Experimentation | Neisseria meningitidis | ARTICLES AND COMMENTARIES | Dosage | Epidemiology | Blood | UNITED-STATES | INFECTIOUS DISEASES | NEW-ZEALAND | PROTECTION | NEISSERIA-MENINGITIDIS | COMPONENTS | ANTIBODY | MICROBIOLOGY | IMMUNOLOGY | MENINGITIDIS GROUP-B | IMMUNOGENICITY | BACTERICIDAL ACTIVITY | NADA | Adhesins, Bacterial - genetics | Humans | Antigens, Bacterial - immunology | Neisseria meningitidis, Serogroup B - immunology | Infant | Male | Neisseria meningitidis, Serogroup B - genetics | Vaccines, Synthetic - immunology | Meningococcal Vaccines - adverse effects | Meningitis, Meningococcal - immunology | Neisseria meningitidis, Serogroup B - chemistry | Vaccines, Synthetic - adverse effects | Drug-Related Side Effects and Adverse Reactions | Female | Immunization Schedule | Antibodies, Bacterial - blood | Bacterial Outer Membrane Proteins - genetics | Serum Bactericidal Antibody Assay | Bacterial Outer Membrane Proteins - immunology | United Kingdom | Meningitis, Meningococcal - prevention & control | Cell Membrane - immunology | Meningococcal Vaccines - immunology | Vaccines, Synthetic - administration & dosage | Adhesins, Bacterial - immunology | Meningococcal Vaccines - administration & dosage | Prevention | Infants (Newborn) | Bacterial meningitis | Research | Demographic aspects | Diseases | Disease prevention | Proteins | Membranes | Immunization | Infectious diseases | Clinical trials | Meningitis | Vaccines | Gram-negative bacteria
Journal Article
Journal Article
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 01/2012, Volume 31, Issue 1, pp. 72 - 77
BACKGROUND:The global distribution of pneumococcal disease and emergence of nonvaccine pneumococcal serotypes prompted the development of a 13-valent... 
13-valent conjugate pneumococcal vaccine | routine vaccines | safety | immunogenicity | Streptococcus pneumoniae | UNITED-STATES | INFECTIOUS DISEASES | INFECTIONS | IMMUNOLOGY | CHILDREN | IMMUNIZATION | STREPTOCOCCUS-PNEUMONIAE | DISEASE | PEDIATRICS | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccination | Vaccines, Conjugate - adverse effects | Infant | Male | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Streptococcus pneumoniae - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Pneumococcal Infections - immunology | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Immunization Schedule | Pneumococcal Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Double-Blind Method | Heptavalent Pneumococcal Conjugate Vaccine | Treatment Outcome | Haemophilus Vaccines - immunology | Vaccines, Conjugate - administration & dosage | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage
Journal Article